In focus · trending topic

lactose intolerance

2 stories · following the connections

Ritter Pharmaceuticals, Inc.’s Board Approves 1-for-10 Reverse Stock Split

By Nasdaq OMXMar 1, 2018, 9:20 PM UTC

Ritter Pharmaceuticals, Inc. Raises $23 Million to Fund Initiation of Its Phase 3 Clinical Program in Lactose Intolerance

By Nasdaq OMXOct 3, 2017, 4:00 PM UTC